May 11, 2026 8:30am EDT FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavirus
May 04, 2026 4:01pm EDT FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring
May 04, 2026 8:30am EDT FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
Apr 30, 2026 5:55pm EDT FibroBiologics Reports Q1 2026 Financial Results and Provides Corporate Update
Apr 30, 2026 8:30am EDT FibroBiologics Announces Poster Presentation at the Society for Investigative Dermatology Annual Meeting 2026
Apr 10, 2026 8:30am EDT FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity